Because all of these organizations use WADA and USADA banned substances list, and BPC-157 is currently classified as Not FDA approved Classified as experimental Peptide with potential performance/recovery effects It will be interesting to see how this changes if/when it gets changed to Category 1, likely later this year by the FDA
Moreover, in the kidney, homocysteine is above all transsulfurated and deficiency of this renal transsulfuration contributes to the elevation of plasma homocysteine [18]
Click the image above to read more
These effects could theoretically make it useful for recovery from strains, tendon injuries, ligament issues, or surgery
*12-month Microdosing Tirzepatide program
This area contains extensive blood vessels lying just beneath a thin layer of epithelial cells